Afuco™ Anti-Human KMA ADCC Therapeutic Antibody (MDX-1097), ADCC Enhanced
Anti-KMA ADCC Enhanced Antibody (MDX-1097) is an ADCC enhanced antibody produced by our Afuco™ platform. IST-1097 (formerly known as MDX-1097) is an antibody for liquid tumors that targets a novel B-cell surface antigen (KMA) that is specific to malignant cells. In Phase 2 clinical development.
Supplier | Creative Biolabs |
---|---|
Product # | AFC-455CL |
Pricing | Inquiry |
Host | Chimeric human/mouse |
Target | KMA |
Species Reactivity | Human |
Type | ADCC enhanced antibody |
Storage |
|